The global breast ultrasound market size valued at USD 2.13 billion in 2018 and is expected to grow at a compound annual growth rate (CAGR) of 14.6% from 2019 to 2026. The demand for breast ultrasound is on a rise owing to the increasing prevalence of breast cancer, technological advancements, and various awareness initiatives undertaken by the governments as well as non-profit organizations.
Rising prevalence of breast cancer across the globe is anticipated to fuel the product demand. Cancer is the second leading cause of death, globally, and breast cancer is one of the most commonly occurring types of the disease among women. As per the World Health Organization (WHO), breast cancer impacts approximately 2.1 million women every year. It also reported that, in 2018, 627,000 women died from the disease, which is about 15.0% of all deaths from cancer among women. According to the International Agency for Research on Cancer (IARC), WHO, Belgium, Luxemburg, Netherlands, and France are the countries with the highest incidence rate of the disease.Such high incidence rate is anticipated to drive the market for breast ultrasound.
According to the European Breast Cancer Coalition, a non-profit organization, the breast cancer incidence in EU-28 was estimated to be 404,920 in 2018. It also reported that in EU-28, 1 in every 8 women is expected to develop the disease before the age of 85. Similarly, as per the IARC, in 2018, the number of new breast cancer cases reported in Latin America and the Caribbean was 199,734, which is 14.1% of all cancer cases.
Rise in sedentary lifestyle, obesity, and changes in eating habits are some of the major factors contributing to breast cancer. Moreover, rising alcohol consumption is also expected to increase the risk of the disease. The risk increases by around 7% to 12% per unit of alcohol consumption per day. Such high prevalence of the diseases is expected to boost the demand for breast ultrasound in near future.
Due to the rising prevalence, the key companies are launching technologically advanced products to strengthen their foothold in the breast ultrasound market. For instance, in October, 2018, GE Healthcare launched Invenia Automated Breast Ultrasound (ABUS) 2.0 in the U.S. This device was specifically designed to detect tumors in dense breast tissues.
Automated breast ultrasound segment held the largest market share in 2018 and is anticipated to witness the fastest growth over the forecast period. The growth is attributed to the availability of a huge number of products, rapid technological advancements, and user-friendly features of this device. Some of the products offered by the key players are Invenia ABUS 2.0 by GE Healthcare, SOFIA 3D breast ultrasound system by Hitachi Ltd., EPIQ ultrasound system by Koninklijke Philips N.V., and ACUSON S2000 by Siemens Healthineers AG.
Conventional breast ultrasound is expected to witness significant growth over the forecast period. It is used to detect the tumor and other breast abnormalities. These devices are, generally, operator dependent, which is expected to restrain the market growth. Moreover, rising adoption of technologically advanced products for better diagnosis is expected to restrict the growth of the market in the forthcoming years.
Hospital segment held the largest market share in 2018and is anticipated to witness a significant CAGR over the forecast period owing to the rising cases of breast cancer worldwide coupled with the launch of technologically advanced products by the key market players. Moreover, initiatives undertaken by the governments and non-profit organizations to raise awareness regarding diagnosis and treatment are also expected to boost the growth.
Diagnostic imaging laboratories segment is anticipated to witness the fastest CAGR over the forecast period owing to the increasing number of diagnostic centers, rising demand for imaging techniques, and high global prevalence of the disease. Moreover, diagnostic imaging helps doctors analyze the condition and determine the medical course. Such factors are expected to further boost the growth of the segment.
In 2018, North America held the largest market share owing to the rising cases of breast cancer and presence of key players in the region. For instance, as per the Breastcancer.org, approximately 12.0% women are diagnosed with invasive breast cancer over the course of their lifetime. It also reported that in 2019, about 268,600 new cases of invasive breast cancer are anticipated to be registered in the country. Such high instance is expected to drive the regional market growth. In addition, presence of key players, such as GE Healthcare, Koninklijke Philips N.V., and Siemens Healthineers AG, is also expected to drive the growth.
Asia Pacific is anticipated to witness the fastest CAGR over the forecast period owing to the rising awareness regarding breast cancer and its treatment procedure. For instance, many organizations in the region organize Breast Cancer Awareness campaign in the month of October every year. This campaign is also organized to raise funds for cancer research and development of technologically advanced treatment procedures.
Key players engage in adopting strategies such as mergers and acquisitions, collaborations, and partnerships to strengthen their market position.
For instance, in August 2019, Hologic, Inc. acquired a 46.0% share of SuperSonic Imagine to integrate the latter’s ultrasound technology and product with its resources to develop better and technologically advanced products for breast cancer patients. This acquisition is anticipated to increase the former’s market foothold in the near future. Some of the prominent players in the breast ultrasound market include:
General Electric Company
Hitachi, Ltd.
Koninklijke Philips N.V.
Siemens Healthineers AG
TELEMED Medical Systems
Canon Medical Systems Corporation
Fukuda Denshi
Hologic; Inc.
Report Attribute |
Details |
Market size value in 2020 |
USD 2.78 billion |
Revenue forecast in 2026 |
USD 6.36 billion |
Growth Rate |
CAGR of 14.6% from 2019 to 2026 |
Base year for estimation |
2018 |
Historical data |
2015 - 2017 |
Forecast period |
2019 - 2026 |
Quantitative units |
Revenue in USD million and CAGR from 2019 to 2026 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, end-use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country scope |
U.S.; Canada; U.K.; Germany; China; Japan; Brazil; Mexico; South Africa; Saudi Arabia |
Key companies profiled |
General Electric Company; Hitachi, Ltd.; Koninklijke Philips N.V.; Siemens Healthineers AG; TELEMED Medical Systems; Canon Medical Systems Corporation; Fukuda Denshi; Hologic; Inc. |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2015 to 2026. For the purpose of this study, Grand View Research has segmented the global breast ultrasound market report on the basis of product, end-use, and region:
Product Outlook (Revenue, USD Million, 2015 - 2026)
Conventional Breast Ultrasound (CBUS)
Automated Breast Ultrasound (ABUS)
End-Use Outlook (Revenue, USD Million, 2015 - 2026)
Hospital
Diagnostics Imaging Laboratories
Others
Regional Outlook (Revenue, USD Million, 2015 - 2026)
North America
The U.S.
Canada
Europe
The U.K.
Germany
Asia Pacific
China
Japan
Latin America
Brazil
Mexico
MEA
South Africa
Saudi Arabia
b. The global breast ultrasound market size was estimated at USD 2.43 billion in 2019 and is expected to reach USD 2.78 billion in 2020.
b. The global breast ultrasound market is expected to grow at a compound annual growth rate of 14.6% from 2019 to 2026 to reach USD 6.36 billion by 2026.
b. North America dominated the breast ultrasound market with a share of 45.4% in 2019. This is attributable to rising cases of breast cancer and presence of key players in the region.
b. Some key players operating in the breast ultrasound market include General Electric Company, Hitachi, Ltd., Koninklijke Philips N.V., Siemens Healthineers AG, TELEMED Medical Systems, Canon Medical Systems Corporation, Fukuda Denshi, and Hologic, Inc.
b. Key factors that are driving the market growth include increasing prevalence of breast cancer, technological advancement, and various initiatives undertaken to raise awareness regarding breast cancer and its treatment.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.
We value your investment and offer free customization with every report to fulfil your exact research needs.